Our Products
We strive to develop unique effective therapies for our patients within our areas of focus. We combine a unique balance between technology and innovation into our drug development and discovery. Our dedicated team of experts make important strides in understanding the patient needs in the areas of Nephrology, Oncology, Immunology & Allergy, and Central Nervous System.
CRYSVITA® (Burosumab)
CRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older.
LUMICEF® (Brodalumab)
LUMICEF is used in the treatment of psoriasis vulgaris that respond inadequately to existing therapies.
NESP® (Darbepoetin alfa)
NESP is used in the treatment of anemia (low red blood cell counts) due to chronic kidney disease (CKD), including patients on dialysis and patients not on dialysis.
PECFENT® (Fentanyl)
PecFent nasal spray is indicated for the management of breakthrough pain (BTP) in adults who are already receiving maintenance opioid therapy for chronic cancer pain.
REGPARA® (Cinacalcet Hydrochloride)
REGPARA is used in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on dialysis.
ROMIPLATE® (Romiplostim)
Romiplate is used in the treatment of thrombocytopenia in adult splenectomised patients with chronic immune (idiopathic) thrombocytopenia purpura (ITP) who have had insufficient response to corticosteroids or immune globulin. In addition, Romiplate is used as second-line treatment for adult non-splenectomised patients where surgery is contraindicated.
SANCUSO® (Granisetron Transdermal System)
Sancuso transdermal system is used in the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy for up to 5 consecutive days.
